IGEA discloses its half-2019 financials 15 August 2019 Hoofddorp, The Netherlands, 15 August 2019. IGEA Pharma N.V. (the “Company” and together with its subsidiaries “IGEA” or the “Group”) today announced the disclosure of its half-2019 financials. Continue reading →
